Phase 4 Hypertension Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are pregnant with one baby (not twins or more)
- People whose pregnancy screening results — including an ultrasound, blood tests, and medical history from the first trimester — show a greater than 1 in 150 chance of developing a serious blood pressure condition called preeclampsia
- People who are less than 16 weeks pregnant at the time of joining the trial
- People who are 18 years of age or older
- People who are willing and able to sign a written consent form agreeing to take part
- People who can be reached by phone and have a stable place to live, so that follow-up appointments are possible
Who may not be able to join:
- People who are pregnant with more than one baby (such as twins or triplets)
- People who are already taking aspirin regularly for another medical condition
- People whose baby has been found to have a serious physical abnormality on ultrasound
- People who have a medical reason that makes it unsafe to take aspirin or a blood-thinning injection called low molecular weight heparin — such as a known allergy to either medication, an active stomach ulcer, a bleeding or clotting disorder, a very low platelet count, recent or ongoing significant bleeding, or a history of a specific reaction to heparin called heparin-induced thrombocytopenia
- People with severe kidney failure (confirm with trial site)
- People who are not able to provide written informed consent
- People who are unlikely to be able to attend follow-up — for example, those living in very remote areas without phone access or in temporary housing
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Georgios Daskalakis, PhD, First Department of Obstetrics and Gynecology, Alexandra Hospital
Phone: +306978275745
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Incidence of Preeclampsia
Can't join this trial?
Data last synced from ClinicalTrials.gov: 6 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.